Get the Stockscreener App
16.94
3.86%
-0.68
Pre-market:
16.28
-0.66
-3.90%
Caredx Inc stock is traded at $16.94, with a volume of 505.68K.
It is down -3.86% in the last 24 hours and down -12.32% over the past month.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
See More
Previous Close:
$17.62
Open:
$17.06
24h Volume:
505.68K
Relative Volume:
0.65
Market Cap:
$1.05B
Revenue:
$312.78M
Net Income/Loss:
$-143.56M
P/E Ratio:
-6.2974
EPS:
-2.69
Net Cash Flow:
$1.22M
1W Performance:
-10.37%
1M Performance:
-12.32%
6M Performance:
-27.82%
1Y Performance:
+103.85%
1-Day Range:
$16.71
$17.41
1-Week Range:
$16.71
$19.23
52-Week Range:
$7.42
$34.84
Caredx Inc Stock (CDNA) Company Profile
Name
Caredx Inc
Sector
Industry
Phone
415-287-2300
Address
8000 MARINA BLVD, BRISBANE, CA
Compare CDNA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
16.94 | 1.05B | 312.78M | -143.56M | 1.22M | -2.69 |
|
TMO
Thermo Fisher Scientific Inc
|
421.85 | 169.62B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
184.96 | 138.06B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
406.65 | 32.79B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
100.26 | 29.99B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
141.22 | 26.61B | 15.41B | 1.37B | 2.11B | 7.50 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-15-25 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Aug-28-24 | Initiated | Wells Fargo | Underweight |
| Aug-19-24 | Upgrade | BTIG Research | Neutral → Buy |
| May-13-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-01-24 | Upgrade | Craig Hallum | Hold → Buy |
| Nov-09-23 | Upgrade | Stephens | Equal-Weight → Overweight |
| Aug-15-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-11-23 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-07-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Mar-03-23 | Downgrade | Craig Hallum | Buy → Hold |
| Mar-03-23 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Apr-25-22 | Initiated | Stephens | Overweight |
| Jul-20-21 | Resumed | BTIG Research | Buy |
| Jun-03-21 | Initiated | Goldman | Buy |
| Feb-26-21 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Oct-30-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-08-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-02-20 | Reiterated | H.C. Wainwright | Buy |
| Aug-05-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-26-20 | Initiated | BTIG Research | Buy |
| Jun-19-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-01-19 | Resumed | Craig Hallum | Buy |
| May-09-19 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Feb-15-19 | Initiated | Jefferies | Buy |
| Oct-23-18 | Resumed | Raymond James | Strong Buy |
| Sep-18-18 | Reiterated | H.C. Wainwright | Neutral |
| Nov-27-17 | Initiated | H.C. Wainwright | Buy |
| Jun-14-16 | Reiterated | Mizuho | Buy |
| Sep-29-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-25-15 | Initiated | Craig Hallum | Buy |
| Mar-18-15 | Reiterated | Mizuho | Buy |
View All
Caredx Inc Stock (CDNA) Latest News
CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) | CDNA Stock News - GuruFocus
CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - Eagle-Tribune
CareDx Strengthens Leadership: New Chief Product Officer Joins with Performance-Based Equity Package - Stock Titan
Lobbying Update: $50,000 of CAREDX INC. lobbying was just disclosed - Nasdaq
CareDx Officer Sells Shares to Satisfy Tax Obligations - TradingView
CareDx's secretary and general counsel sells shares worth $16,373 By Investing.com - Investing.com India
CareDx’s secretary and general counsel sells shares worth $16,373 - Investing.com Australia
CareDx's secretary and general counsel sells shares worth $16,373 - Investing.com
CareDx CFO Abhishek Jain sells shares worth $4,695 - Investing.com
Healthcare Tech Pioneer CareDx Set to Unveil Q1 2025 Performance Data - Stock Titan
CareDx to Report First Quarter 2025 Financial Results - The Joplin Globe
Prudential Financial Inc. Purchases 103,862 Shares of CareDx, Inc (NASDAQ:CDNA) - MarketBeat
CareDx CFO secures new severance agreement terms - Investing.com Australia
CareDx CFO secures new severance agreement terms By Investing.com - Investing.com South Africa
CAREDX INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc.CDNA - Business Wire
CareDx Updates CFO Severance Agreement Amid Leadership Changes - TipRanks
CareDx Inc (CDNA) Shares Gap Down to $18.22 on Mar 26 - GuruFocus
CareDx Releases Two Expanded Indications for AlloSure Testing Services - Medical Product Outsourcing
SHAREHOLDER ALERT: Kaskela Law LLC Announces Class Action - GlobeNewswire
Judge Connolly (D. Del.) Overturns $96 Million Molecular Diagnostics Jury Verdict, Finds Patents Invalid Under § 112 - JD Supra
Trend Tracker for (CDNA) - news.stocktradersdaily.com
Cathie Wood's Ark Invest Continues To Offload UiPath, Roblox: Loads Up On GitLab, Ibotta - Benzinga
CAREDX INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc.CDNA - PR Newswire
CareDx Launches Two Expanded Indications for AlloSure Testing Services - Diagnostic and Interventional Cardiology
CareDx, Inc (NASDAQ:CDNA) Shares Bought by US Bancorp DE - Defense World
CareDx: Some Litigation Clouds Have Cleared - Seeking Alpha
CareDx director George Bickerstaff sells $367,102 in common stock - Investing.com India
CareDx Director Makes Significant Stock Sale! - TipRanks
CareDx director George Bickerstaff sells $367,102 in common stock By Investing.com - Investing.com UK
Why CareDx's (NASDAQ:CDNA) Earnings Are Weaker Than They Seem - simplywall.st
Major Breakthrough: CareDx AlloSure Now Covers Infant Heart and Dual-Organ Transplant Testing - Stock Titan
Principal Financial Group Inc. Has $406,000 Stock Position in CareDx, Inc (NASDAQ:CDNA) - Defense World
Statutory Earnings May Not Be The Best Way To Understand CareDx's (NASDAQ:CDNA) True Position - Yahoo Finance
HC Wainwright Has Negative Estimate for CareDx Q1 Earnings - Defense World
(CDNA) On The My Stocks Page - news.stocktradersdaily.com
Rhumbline Advisers Boosts Stake in CareDx, Inc (NASDAQ:CDNA) - Defense World
New York State Common Retirement Fund Sells 15,584 Shares of CareDx, Inc (NASDAQ:CDNA) - Defense World
CareDx (NASDAQ:CDNA) Trading Down 7.9% Following Analyst Downgrade - Defense World
CareDx stock price target cut to $25 at H.C. Wainwright By Investing.com - Investing.com Canada
CareDx (NASDAQ:CDNA) Price Target Cut to $25.00 by Analysts at HC Wainwright - Defense World
CareDx stock price target cut to $25 at H.C. Wainwright - Investing.com
Where CareDx Stands With Analysts - Benzinga
CareDx, Inc (NASDAQ:CDNA) Shares Sold by ARK Investment Management LLC - MarketBeat
CareDx (NASDAQ:CDNA) Shares Gap Up Following Strong Earnings - Defense World
Decoding CareDx Inc (CDNA): A Strategic SWOT Insight - GuruFocus.com
CareDx (NASDAQ:CDNA) Upgraded by StockNews.com to "Buy" Rating - MarketBeat
CareDx, Inc (NASDAQ:CDNA) Q4 2024 Earnings Call Transcript - MSN
Bradley & Co. Private Wealth Management LLC Invests $269,000 in CareDx, Inc (NASDAQ:CDNA) - MarketBeat
Caredx Inc Stock (CDNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):